Congress wants Justice Dept. to investigate whether former AL MVP Miguel Tejada lied to group Print
Written by Admin   
Tuesday, 15 January 2008 07:02
MLB Headline News

 WASHINGTON (AP) - Congress asked the Justice Department to investigate whether former AL MVP Miguel Tejada lied to House committee staff when he was interviewed in 2005 in connection with the Rafael Palmeiro steroids case.
House Oversight and Government Committee chairman Henry Waxman opened Tuesday's hearing into the Mitchell Report about drug use in baseball by announcing that he and ranking minority member Tom Davis sent a letter to Attorney General Michael Mukasey on Tuesday.
``Tejada told the committee that he never used illegal performance-enhancing drugs and that he had no knowledge of other players using or even talking about steroids,'' Waxman said. ``Well, the Mitchell Report, however, directly contradicts key elements of Mr. Tejada's testimony.''
Said Davis: ``We've concluded further investigation is warranted.''
When the same House panel held a hearing in March 2005, Palmeiro pointed at the panel and declared: ``I have never used steroids, period.'' Palmeiro was suspended by baseball later that year after testing positive for a steroid.
The committee later looked into whether Palmeiro should face perjury charges, but eventually dropped the matter.
Palmeiro said his positive test must have resulted from a B-12 vitamin injection given to him by Tejada. That prompted Congress to talk to Tejada, who at the time was a Baltimore Orioles teammate of Palmeiro's. Tejada was traded to the Houston Astros on Dec. 12.
The letter contains excerpts from the Aug. 26, 2005, interview of Tejada at a hotel in Baltimore. At the time, he and Palmeiro played for the Orioles.
``Has there been discussion among other players about steroids?'' a committee staffer asked, according to the letter.
``No, I never heard,'' Tejada replied.
``You never knew of any other player using steroids?'' Tejada was asked.
``No,'' he replied.
``Have you ever taken a steroid before?'' he was asked at another point.
``No,'' he said.
Tejada also answered ``No'' when asked whether he had ever taken any illegal performance-enhancing drugs, andro or any other steroid precursor.
The letter then quotes a portion of the Mitchell Report in which Tejada's former Oakland Athletics teammate Adam Piatt said he discussed steroid use with Tejada, and ``recalled that he provided Tejada with testosterone or Deca-Durabolin, as well as human growth hormone.''
Tejada's agent, Fern Cuza, didn't respond to a telephone message or e-mail.
 

MLB Team Pages

Top MLB Public Bets

#1 902 Kansas City Royals 51%
View All: NFL |  NBA |  NCAAF |  NCAAB |  MLB |  NHL

MLB Futures

MLB TEAM WORLD SERIES ODDS CURRENT
SAN FRANCISCO GIANTS 10/11
KANSAS CITY ROYALS 10/11
TORONTO BLUE JAYS OFF
BOSTON RED SOX OFF
MINNESOTA TWINS OFF
SAN DIEGO PADRES OFF
MIAMI MARLINS OFF
WASHINGTON NATIONALS OFF
CHICAGO CUBS OFF
NEW YORK METS OFF
View All

Privacy Policy | Terms of Service | Contact Us | Advertising | 888-99-SPREAD

THIS IS NOT A GAMBLING SITE – If you think you have a gambling problem click here.

Disclaimer: This site is for informational and entertainment purposes only. Individual users are responsible for the laws regarding accessing gambling information from their jurisdictions. Many countries around the world prohibit gambling, please check the laws in your location. Any use of this information that may violate any federal, state, local or international law is strictly prohibited.

Copyright: The information contained on TheSpread.com website is protected by international copyright and may not be reproduced, or redistributed in any way without expressed written consent.

About: TheSpread.com is the largest sports betting news site in the United States. We provide point spread news, odds, statistics and information to over 199 countries around the world each year. Our coverage includes all North American College and Professional Sports as well as entertainment, political and proposition wagering news.

©1999-2013 TheSpread.com